Administration of MS-275 Improves Cognitive Performance and Reduces Cell Death Following Traumatic Brain Injury in Rats.

CONCLUSION: Our present data highlight the fact that MS-275 may provide neuroprotective effect and improve cognitive performance after TBI. We concluded that MS-275 is a potential novel treatment and will have an ameliorative effect on some of the pathological features associated with TBI. PMID: 23551690 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23551690?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - May 1, 2013 Category: Neuroscience Authors: Cao P, Liang Y, Gao X, Zhao MG, Liang GB Tags: CNS Neurosci Ther Source Type: research